The association of 6-minute walk performance and outcomes in stable outpatients with heart failure.

BACKGROUND We sought to evaluate the prognostic value of the 6-minute walk test in stable outpatients with heart failure. METHODS AND RESULTS We examined the association of 6-minute walk test distance and outcomes among 541 patients enrolled in the Digitalis Investigation Group trial. Patients were grouped by total distance (< or =200 m, 201 m-300 m, 301 m-400 m, and >400 m) with median follow-up of 32 months. All-cause mortality for patients who walked < or =200 m was significantly higher than patients who walked >200 m (43.9% versus 23.3%, P<0.001), but mortality was comparable among patients who walked >200 m (201 m-300 m: 23.7%, 301 m-400 m: 25.2%, >400 m 19.8%, P for trend 0.45). Results were similar for death due to worsening heart failure (< or =200 m: 29.3%, 201 m-300 m: 7.6%, 301 m-400 m: 6.7%, >400 m: 6.1%, P for trend <0.001). In multivariable analysis, distance < or =200 m remained associated with increased mortality (< or =200 m: hazard ratio (HR) 1.47, 95% CI 0.96-2.27; >200 m: HR 1.00, Referent; P=0.07) and death due to worsening heart failure (< or =200 m: HR 2.89, 95% CI 1.54-5.41; >200 m: 1.00, Referent; P=0.001). CONCLUSIONS The 6-minute walk test identifies patients who walk less than 200 m as being at markedly increased risk of death. Changing the 6-minute walk test to a time- and distance-based standard would improve the efficiency of the test while retaining the bulk of the prognostic information.

[1]  A Negassa,et al.  Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. , 2001, American heart journal.

[2]  D. M. Barr,et al.  Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. , 1996, Controlled clinical trials.

[3]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[4]  S. Yusuf,et al.  Natural history and patterns of current practice in heart failure , 1993 .

[5]  L. Cahalin,et al.  The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. , 1996, Chest.

[6]  Bittner,et al.  Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. , 1993, JAMA.

[7]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[8]  J H Patterson,et al.  Relation between gender, etiology and survival in patients with symptomatic heart failure. , 1996, Journal of the American College of Cardiology.

[9]  V. Hasselblad,et al.  Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. , 2001, The American journal of cardiology.

[10]  L. Tavazzi,et al.  Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? , 2001, European heart journal.

[11]  G. Gensini,et al.  Prognostic value of 6-minute walk corridor testing in women with mild to moderate heart failure. , 2002, Italian heart journal : official journal of the Italian Federation of Cardiology.

[12]  G. Roul,et al.  Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? , 1998, American heart journal.

[13]  S. O’Keeffe,et al.  Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients , 1998, Heart.

[14]  M. Drazner,et al.  Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. , 2001, The New England journal of medicine.

[15]  William J. Rogers,et al.  Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction , 1993 .

[16]  A. Ferreira,et al.  Predictors of prognosis in patients with stable mild to moderate heart failure. , 2000, Journal of cardiac failure.

[17]  C M O'Connor,et al.  Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. , 1997, Journal of the American College of Cardiology.

[18]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[19]  V. Bittner.  Determining prognosis in congestive heart failure: role of the 6-minute walk test. , 1999, American Heart Journal.

[20]  G. Guyatt,et al.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. , 1985, Canadian Medical Association journal.

[21]  Harlan M Krumholz,et al.  Sex-based differences in the effect of digoxin for the treatment of heart failure. , 2002, The New England journal of medicine.

[22]  D. V. Lindley,et al.  Applied nonparametric statistical methods , 1988 .

[23]  L. Stevenson,et al.  The 6-min walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival. , 1999, American heart journal.

[24]  P Royston,et al.  The use of fractional polynomials to model continuous risk variables in epidemiology. , 1999, International journal of epidemiology.

[25]  C. Borror.  Nonparametric Statistical Methods, 2nd, Ed. , 2001 .